This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garcia-Villalba, P.
Right arrow Articles by Aranda, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garcia-Villalba, P.
Right arrow Articles by Aranda, A.

 Previous Article  |  Next Article 

Mol. Cell. Biol., 01 1996, 318-327, Vol 16, No. 1
Copyright © 1996, American Society for Microbiology

Vitamin D interferes with transactivation of the growth hormone gene by thyroid hormone and retinoic acid

P Garcia-Villalba, AM Jimenez-Lara and A Aranda
Instituto de Investigaciones Biomedicas, Consejo Superior de Investigaciones Cientificas, Madrid, Spain.

The thyroid hormone, retinoic acid (RA), and vitamin D regulate gene expression by binding to similar receptors which act as ligand- inducible transcription factors. Incubation of pituitary GH4C1 cells with nanomolar concentrations of vitamin D markedly reduces the response of the rat growth hormone mRNA to thyroid hormone triiodothyronine (T3) and RA. The stimulation of growth hormone gene expression by both ligands is mediated by a common hormone response element (TREGH) present in the 5'-flanking region of the gene, and the inhibition caused by vitamin D is due to transcriptional interference of the vitamin D receptor on this DNA element. No inhibition of the basal promoter activity by the vitamin was observed. The response to T3 and RA of a heterologous promoter containing this element, the palindromic T3- and RA-responsive sequence TREPAL, or a direct repeat of the same motif is also inhibited by vitamin D. In contrast, vitamin D strongly induces the activity of constructs containing a vitamin D response element, and neither T3 nor RA reduces vitamin D-mediated transactivation. Transfection with an expression vector for the retinoid X receptor alpha (RXR alpha) increases transactivation by T3 and RA but does not abolish the inhibition caused by the vitamin. Gel retardation experiments show that the vitamin D receptor (VDR) as a heterodimer with RXR weakly binds to the T3- and RA-responsive elements. Additionally, VDR displaces binding of T3 and RA receptors in a dose-dependent manner. Our data suggest the formation of TR-VDR and RAR-VDR heterodimers with RXR. The fact that the same response element mediates opposite effects of at least four different nuclear receptors provides a greater complexity and flexibility of the transcriptional responses to their ligands.


This article has been cited by other articles:

  • Castillo, A. I., Sanchez-Martinez, R., Jimenez-Lara, A. M., Steinmeyer, A., Zugel, U., Aranda, A. (2006). Characterization of Vitamin D Receptor Ligands with Cell-Specific and Dissociated Activity. Mol. Endocrinol. 20: 3093-3104 [Abstract] [Full Text]  
  • Scsucova, S., Palacios, D., Savignac, M., Mellstrom, B., Naranjo, J. R., Aranda, A. (2005). The repressor DREAM acts as a transcriptional activator on Vitamin D and retinoic acid response elements. Nucleic Acids Res 33: 2269-2279 [Abstract] [Full Text]  
  • Schneider, L., El-Yazidi, C., Dace, A., Maraninchi, M., Planells, R., Margotat, A., Torresani, J. (2005). Expression of the 1,25-(OH)2 vitamin D3 receptor gene during the differentiation of mouse Ob17 preadipocytes and cross talk with the thyroid hormone receptor signalling pathway. J Mol Endocrinol 34: 221-235 [Abstract] [Full Text]  
  • Bastie, J.-N., Balitrand, N., Guidez, F., Guillemot, I., Larghero, J., Calabresse, C., Chomienne, C., Delva, L. (2004). 1{alpha},25-Dihydroxyvitamin D3 Transrepresses Retinoic Acid Transcriptional Activity via Vitamin D Receptor in Myeloid Cells. Mol. Endocrinol. 18: 2685-2699 [Abstract] [Full Text]  
  • Castillo, A. I., Sanchez-Martinez, R., Moreno, J. L., Martinez-Iglesias, O. A., Palacios, D., Aranda, A. (2004). A Permissive Retinoid X Receptor/Thyroid Hormone Receptor Heterodimer Allows Stimulation of Prolactin Gene Transcription by Thyroid Hormone and 9-cis-Retinoic Acid. Mol. Cell. Biol. 24: 502-513 [Abstract] [Full Text]  
  • Yen, P. M. (2001). Physiological and Molecular Basis of Thyroid Hormone Action. Physiol. Rev. 81: 1097-1142 [Abstract] [Full Text]  
  • Aranda, A., Pascual, A. (2001). Nuclear Hormone Receptors and Gene Expression. Physiol. Rev. 81: 1269-1304 [Abstract] [Full Text]  
  • Williams, G. R. (2000). Cloning and Characterization of Two Novel Thyroid Hormone Receptor beta Isoforms. Mol. Cell. Biol. 20: 8329-8342 [Abstract] [Full Text]  
  • POLLY, P., HERDICK, M., MOEHREN, U., BANIAHMAD, A., HEINZEL, T., CARLBERG, C. (2000). VDR-Alien: a novel, DNA-selective vitamin D3 receptor-corepressor partnership. FASEB J. 14: 1455-1463 [Abstract] [Full Text]  
  • Castillo, A. I., Jimenez-Lara, A. M., Tolon, R. M., Aranda, A. (1999). Synergistic Activation of the Prolactin Promoter by Vitamin D Receptor and GHF-1: Role of the Coactivators, CREB-Binding Protein and Steroid Hormone Receptor Coactivator-1 (SRC-1). Mol. Endocrinol. 13: 1141-1154 [Abstract] [Full Text]  
  • Jiménez-Lara, A. M., Aranda, A. (1999). Vitamin D Represses Retinoic Acid-Dependent Transactivation of the Retinoic Acid Receptor-{beta}2 Promoter: The AF-2 Domain of the Vitamin D Receptor Is Required for Transrepression. Endocrinology 140: 2898-2907 [Abstract] [Full Text]  
  • JIMENEZ-LARA, A. M., ARANDA, A. (1999). The vitamin D receptor binds in a transcriptionally inactive form and without a defined polarity on a retinoic acid response element. FASEB J. 13: 1073-1081 [Abstract] [Full Text]  
  • Jimenez-Lara, A. M., Aranda, A. (1999). Lysine 246 of the Vitamin D Receptor Is Crucial for Ligand-dependent Interaction with Coactivators and Transcriptional Activity. J. Biol. Chem. 274: 13503-13510 [Abstract] [Full Text]  
  • Palomino, T., Barettino, D., Aranda, A. (1998). Role of GHF-1 in the Regulation of the Rat Growth Hormone Gene Promoter by Thyroid Hormone and Retinoic Acid Receptors. J. Biol. Chem. 273: 27541-27547 [Abstract] [Full Text]  
  • Tolon, R. M., Castillo, A. I., Aranda, A. (1998). Activation of the Prolactin Gene by Peroxisome Proliferator-activated Receptor-alpha Appears to Be DNA Binding-independent. J. Biol. Chem. 273: 26652-26661 [Abstract] [Full Text]  
  • Palomino, T., Sánchez-pacheco, A., Peña, P., Aranda, A. (1998). A direct protein-protein interaction is involved in the cooperation between thyroid hormone and retinoic acid receptors and the transcription factor GHF-1. FASEB J. 12: 1201-1209 [Abstract] [Full Text]